Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases

Size: px
Start display at page:

Download "Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases"

Transcription

1 Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases M. Trauner, Division of Gastroenterology and Hepatology, Department of Internal Medicine, MUG Co- Investigator: H. Samonigg, Division of Oncology, Department of Internal Medicine, MUG

2 Project aims Associate prospectively collected human tissue and blood samples with detailed patient information - Clinical presentation, disease course & outcome - Family history, life style, additional diseases, medication Cross-validate mouse models and corresponding human diseases - Metabolic liver diseases and liver cancer

3 Metabolic and neoplastic diseases Metabolism (obesity, diabetes, iron) & cancer - Liver, breast, colorectal, Chronic inflammatory liver / bowel disease cancer (end of a spectrum) - Fatty liver steatohepatitis cirrhosis HCC - Chronic hepatitis cirrhosis HCC - Ulcerative colitis dysplasia / DALM - CRC Underlying liver / GI disease + cancer

4 NAFLD: Spectrum of Hepatic Pathology Chronic metabolic liver disease leading to cancer Steatosis Steatohepatitis HCC Cirrhosis HCC Modified after: A. M. Diehl, AGA Slide Series

5 Prospective collection & annotation of patient samples Prospective collection of medical data and sera of patients undergoing liver and intestinal biopsies Serum samples from liver outpatients before, during and after therapy (including LTx) Serum samples from cancer outpatients before, during and after medical / surgical therapy

6 Lifestyle and family questionnaire Liver and oncology outpatient clinic Number of pages: 16, option for automatic scanning Time effort: 30 min for patients and 10 min for M.D. Patient acceptance: very high (99%) Personal and medical history: - Nutrition (3 pages) - Alcohol / nicotine consumption (2 p) - Physical activity (3 p, collaboration with Institute of Sports Medicine) - Past medical history (2 p) - Family history (5 p) - Medication (1 p) Number of life style questionnaires - Liver outpatient clinic: Oncology outpatient clinic: 741

7 Achieved project aims Prospective collection of serum und tissue samples consistent SOPs Centralized sample management Actual number of tissue samples: liver biopsies (23 chronic viral hepatitis, 11 fatty liver, 12 steatohepatitis, 11 cholestatic liver disease, 7 autoimmune hepatitis, 23 other etiology) intestinal biopsies (31 Crohn s disease, 19 ulcerative colitis, 9 normal controls, 77 other etiology) Actual number of serum samples: non-neoplastic liver diseases (viral, cholestatic, metabolic) - 35 hepatocellular carcinomas non-hepatic cancers (3.488 colon, rectal, breast) Merging of clinical und molecular data

8 Project aims Associate prospectively collected human tissue and blood samples with detailed patient information Cross-validate mouse models and corresponding human diseases - Metabolic liver diseases and liver cancer

9 Cross-validation of mouse models for metabolic liver diseases & liver cancer Cholesterol Mdr2 -/- mice BD BD Bile acids BD Bsep X X Abcg5/8 X Mdr2 PL MDR3 Mutations -PFIC3 (progressive familial intrahepatic cholestasis) -Sclerosing cholangitis -Intrahepatic cholestasis of pregnancy -Intrahepatic cholelithiasis -Drug induced cholestasis -Adult biliary cirrhosis Cftr Cl - Fickert et al, Gastroenterology, 2002 Lammert et al., Hepatology, 2004 Pikarsky et al., Nature 2004 Toxic bile Trauner et al, Wien Med Wochenschr, 2008 Ziol et al., Gastroenterology, 2008 AE2 induced bile duct injury HCO 3 - Cl -

10 Interdisciplinary experimental projects Morphological Characterization of Hepatic Carcinogenesis in the Mdr2-/- Mouse Model Department of Internal Medicine Division of Gastroenterology and Hepatology, Medical University of Graz Departement of Pathology, Medical University Graz Chromosomal instability in tumor development in Mdr2-/- mice Department of Internal Medicine Division of Gastroenterology and Hepatology, Medical University of Graz Departement of Medical Biology and Genetics, Medical University Graz Effects of 24-nor-UDCA in a hepatocellular carcinoma xenograft nude mouse model Department of Internal Medicine Division of Gastroenterology and Hepatology, Medical University of Graz Departement of Pathology, Medical University Graz

11 Publications funded by GATiB project (1/4) Side-chain-modification critically determines the physiologic and therapeutic properties of 24-norUrsodeoxycholic Acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) Knockout Mice Emina Halilbasic 1, Peter Fickert 1, Romina Fiorotto 2, Hanns-Ulrich Marschall 3, Tarek Moustafa 1, Andrea Fuchsbichler 4, Judith Gumhold 1, Dagmar Silbert 1, Kurt Zatloukal 4, Cord Langner 4, Uday Maitra 5, Helmut Denk4, Mario Strazzabosco 2, and Michael Trauner 1 1 Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Medicine, Medical University Graz, Austria; 2 Section of Digestive Diseases, Department of Internal Medicine, School of Medicine, Yale University, New Haven, USA; 3 Karolinska University Hospital Huddinge, Stockholm, Sweden; 4 Institute of Pathology, Medical University Graz, Austria; 5 Departement of Organic Chemistry, Indian Institute of Science, Bangalore, India Hepatology 2009;49(6):

12 norudca as novel treatment for chronic liver injury and biliary fibrosis in Mdr2 -/- mouse model norudca T-norUDCA bis-nor norudca PL x Mdr2 -/- Anti-infammatory Anti-fibrotic Anti-proliferative Cholehepatic Shunting HCO 3 - Differences in HCO 3 - -rich Hypercholeresis Halilbasic et al., Hepatology, 2009

13 Cross-validation of mouse models for metabolic liver diseases & liver cancer Cholesterol Bile acids X FXR Bsep Abcg5/8 X Mdr2 PL WT Mdr2 -/- Mdr2/FXR DKO Cftr Cl - AE2 HCO 3 - Cl - Toxic bile induced bile duct injury

14 Summary Prospective collection of human tissue and blood samples with detailed clinical data from patients with metabolic and neoplastic disorders Cross-validation of corresponding mouse models

15 Thank you for your attention!

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

BACKGROUND MEDIA INFORMATION Fast facts about liver disease BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of

More information

Abnormal Liver Tests and Fatty Liver Disease

Abnormal Liver Tests and Fatty Liver Disease Abnormal Liver Tests and Fatty Liver Disease Michael D Voigt MD Medical Director Liver Failure and Transplantation, University of Iowa Hospital and Clinics Conflict of interest: I sadly have nothing to

More information

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct)

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Section 1 Service Details Service ID: 7540540 Service Comments: Referrer Alert: Service

More information

Bile Duct Diseases and Problems

Bile Duct Diseases and Problems Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.

More information

Indications in Hepatology and Liver Diseases

Indications in Hepatology and Liver Diseases exclusively working in Health Care sananet GmbH Tilo Stolzke Breite Str. 6-8 23562 Lübeck Germany Telefon : +49 451 400 8301 Telefax : +49 451 400 8302 E-Mail : stolzke@sananet.com Internet : www.sananet.com

More information

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing

More information

Ansh. Liver Clinic. Prevention to Cure. Dr. Jayshri A. Shah. Dr. Ankur J. Shah. For Appointments : l

Ansh. Liver Clinic. Prevention to Cure. Dr. Jayshri A. Shah. Dr. Ankur J. Shah. For Appointments : l (Division of ANSH MEDICARE SOLUTIONS PVT. LTD.) CIN : U74999MH2016PTC284829 Dr. Jayshri A. Shah MD, DNB, MNAMS, MRCP (UK), CCST (UK) Consultant Hepatologist, Gastroenterologist, Endoscopist Dr. Ankur J.

More information

Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH Nonalcoholic steatohepatitis

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School

More information

Alcohol Liaison Service. Liver Disease. Information

Alcohol Liaison Service. Liver Disease. Information Alcohol Liaison Service Liver Disease Information Introduction Most liver diseases do not show symptoms and when they do, the symptoms are often vague. There are hundreds of liver disorders and some are

More information

PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO

PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO Steatosi e Steatoepatite PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO Alcoholic liver disease Liver damage resulting from long-term alcohol consumption Histological features:

More information

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common

More information

Program of the ESPGHAN Hepatology Summer School 2010

Program of the ESPGHAN Hepatology Summer School 2010 Program of the ESPGHAN Hepatology Summer School 2010 Organized by: ESPGHAN Hepatology Committee Date: 13-16th May 2010 Venue: Hotel Campanile - Cracow,, Poland Local organizer: Prof. Piotr Socha The Children

More information

THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points

THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points December 2008 (Vol. 1, Issue 3, pages 36-40) THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES By Sophie Lotersztajn, PhD, Ariane Mallat, MD, PhD Inserm U841, Hôpital Henri Mondor,

More information

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY Introduction The BSc in Gastroenterology and Hepatology allows a science-based study of the physiology, cell biology, pathology and pharmacology

More information

Obstructive Jaundice. Dr Eyad Alqarqaz

Obstructive Jaundice. Dr Eyad Alqarqaz Obstructive Jaundice Dr Eyad Alqarqaz Objectives - Know the definition of jaundice - Have an idea about the causes of jaundice in general - Know the causes, investigations and management of obstructive

More information

Liver Cancer What is the liver? What is liver cancer?

Liver Cancer What is the liver? What is liver cancer? Liver Cancer What is the liver? The liver is the largest internal organ in the body and is important in digesting food. The liver performs many other functions, including collecting and filtering blood

More information

Alcoholic and Non-Alcoholic Fatty Liver Disease

Alcoholic and Non-Alcoholic Fatty Liver Disease Alcoholic and Non-Alcoholic Fatty Liver Disease Thomas W. Faust, M.D., M.B.E. Professor of Clinical Medicine Division of Gastroenterology The University of Pennsylvania Alcoholic Liver Disease Additional

More information

HCC: Risk factors, surveillance and the importance of a multidisciplinary team

HCC: Risk factors, surveillance and the importance of a multidisciplinary team HCC: Risk factors, surveillance and the importance of a multidisciplinary team Anjana Pillai MD Assistant Professor of Medicine Director, Emory University Hospital Liver Tumor Clinic Division of Digestive

More information

Liver Transplant. Liver Transplant Payment Policy Policy number M.TSO , effective 03/01/2013. Page 1

Liver Transplant. Liver Transplant Payment Policy Policy number M.TSO , effective 03/01/2013. Page 1 Liver Transplant I. Policy University Health Alliance (UHA) will reimburse for a liver transplant when it is determined to be medically necessary and when it meets the medical criteria guidelines (subject

More information

Liver Enzymes. AST and ALT (Transaminases)

Liver Enzymes. AST and ALT (Transaminases) Liver Enzymes Four separate liver enzymes are included on most routine laboratory tests. They are- aspartate aminotransferase (AST or SGOT) and alanine aminotransferase (ALT or SGPT), which are known together

More information

Liver, Gallbladder, Exocrine Pancreas KNH 406

Liver, Gallbladder, Exocrine Pancreas KNH 406 Liver, Gallbladder, Exocrine Pancreas KNH 406 2007 Thomson - Wadsworth LIVER Anatomy - functions With disease blood flow becomes obstructed Bile All bile drains into common hepatic duct Liver Bile complex

More information

UCLA Asian Liver Program

UCLA Asian Liver Program CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,

More information

DIVISION OF LIVER DISEASES

DIVISION OF LIVER DISEASES The Liver Disease Fellowship at Mount Sinai is the largest program of its kind in the United States. DIVISION OF LIVER DISEASES DR. SCOTT FRIEDMAN serves on the governing board of the American Association

More information

HMM 4401 Gastrointestinal disease

HMM 4401 Gastrointestinal disease HMM 4401 Gastrointestinal disease Ett sykehus - nær deg og dine Admissions to inpatient hospital, > 70 yrs Main diagnoses Blefjell hospital, all dep Patient admissions Cancer and cancer related 500 Cardiovascular

More information

GI Bleeding. Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics

GI Bleeding. Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics GI Bleeding Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics Overview Because GI bleeding is internal, it is possible for a person to have GI bleeding without symptoms. Important to recognize

More information

Liver function. coffee & health topics. Contents. Please see for recent updates on this topic. Page.

Liver function. coffee & health topics. Contents. Please see  for recent updates on this topic. Page. Contents coffee & health topics Intended for professional audiences Page 1 Summary 2 2 in Europe 2 3 Coffee consumption and liver function 3 4 Potential mechanisms 4 5 Conclusion 4 6 References 5 Please

More information

LIVER CANCER AND TUMOURS

LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood

More information

Elevated Liver Enzymes Workup, When to Worry, When to Refer

Elevated Liver Enzymes Workup, When to Worry, When to Refer Elevated Liver Enzymes Workup, When to Worry, When to Refer Ontario College of Family Physicians Annual Scientific Assembly Barry Lumb No disclosures Liver Biochemistry Bilirubin Hepatocellular - AST,

More information

Abdominal pain. Agnieszka Dobrowolska- Zachwieja, MD, PhD Department of Gastroenterology and Human Nutrition

Abdominal pain. Agnieszka Dobrowolska- Zachwieja, MD, PhD Department of Gastroenterology and Human Nutrition Abdominal pain Agnieszka Dobrowolska- Zachwieja, MD, PhD Department of Gastroenterology and Human Nutrition Most common symptoms of abdominal disease Pain Nausea and/or vomiting Change in bowel movements

More information

Liver Cancer And Tumours

Liver Cancer And Tumours Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can

More information

HBV & HCV induced. Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences

HBV & HCV induced. Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences HBV & HCV induced Liver Cirrhosis Iradj Maleki MD Gut & Liver Research Center Mazandaran University of Medical Sciences Definition of Cirrhosis Final pathway for a wide variety of chronic liver diseases

More information

35 Stomach Intestine Contents

35 Stomach Intestine Contents Stomach Intestine 35 36 Prof. Dr. med. Ayman Agha Head of Department Department for General-, Visceral-, Endocrine and Minimally Invasive Surgery > Bogenhausen Hospital Englschalkinger Straße 77 81925

More information

HEPATOLOGY CLERKSHIP

HEPATOLOGY CLERKSHIP College of Osteopathic Medicine HEPATOLOGY CLERKSHIP Office for Clinical Affairs 515-271-1629 FAX 515-271-1727 Elective Rotation General Description This elective rotation is a four (4) week introductory,

More information

NUTR Therapeutic Nutrition I.

NUTR Therapeutic Nutrition I. NUTR 301 - Therapeutic Nutrition I. C O U R S E I N F O R M A T I O N Course Title: Therapeutic Nutrition I. Code: NUTR 301. Hours: Lec 3 Hr. Lab 2Hrs. Cln 0 Hr. Cr.Hr. 4. Prerequisite: NUTR 206. Level/Semester:

More information

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic

What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic Introduction Elevated liver enzymes is often not a clinical problem by itself. However it is a warning

More information

Liver Cancer and Clinical Trials

Liver Cancer and Clinical Trials Liver Cancer and Clinical Trials Abby Siegel MD, MS Medical Director, Hepatobiliary Oncology Columbia University Medical Center Tony Wang MD Assistant Professor, Radiation Oncology, Columbia University

More information

190.25 - Alpha-fetoprotein

190.25 - Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

PREGNANCY AND THE LIVER

PREGNANCY AND THE LIVER Imtiaz Alam, M.D. Phone: [512] 719-4370 Mandy Mishra, CNS Fax: [512] 719-4371 Austin Hepatitis Center 12201, Renfert Way Suite 235 Austin, TX 78758 PREGNANCY AND THE LIVER How does pregnancy affect the

More information

Treatment Advances for Liver Cancer

Treatment Advances for Liver Cancer Treatment Advances for Liver Cancer Guest Expert: Wasif, MD Associate Professor of Medical Oncology Mario Strazzabosco, MD Professor of Internal Medicine, Digestive Diseases www.wnpr.org www.yalecancercenter.org

More information

understanding CIRRHOSIS of the liver A patient s guide from your doctor and

understanding CIRRHOSIS of the liver A patient s guide from your doctor and understanding CIRRHOSIS of the liver A patient s guide from your doctor and Cirrhosis Basics The liver is one of the most important organs in your body and weighs about 3 pounds. It sits in the upper right

More information

Leading the Way to Treat Liver Cancer

Leading the Way to Treat Liver Cancer Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale

More information

Patient information: Nonalcoholic steatohepatitis (NASH)

Patient information: Nonalcoholic steatohepatitis (NASH) Official reprint from UpToDate www.uptodate.com 2011 UpToDate The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek

More information

SHAHID AZIZ DO, FACOI.

SHAHID AZIZ DO, FACOI. SHAHID AZIZ DO, FACOI. ASSOCIATE CLINICAL PROFESSOR OF GI AND LIVER DISEASE. UT SOUTHWESTERN HEALTH SCIENCE CENTER, DALLAS ADJUNCT CLINICAL ASSISTANT PROFESSOR DEPT OF MEDICINE UNT HEALTH SCIENCE CENTER

More information

Non-alcoholic Fatty Liver Disease. Christi Matteoni, MD GI Consultants

Non-alcoholic Fatty Liver Disease. Christi Matteoni, MD GI Consultants Non-alcoholic Fatty Liver Disease Christi Matteoni, MD GI Consultants Definition of NAFLD Evidence of hepatic steatosis by imaging or histology No causes for secondary hepatic fat accumulation Significant

More information

Bleeding in the Digestive Tract

Bleeding in the Digestive Tract Bleeding in the Digestive Tract Bleeding in the digestive tract is a symptom of a disease rather than a disease itself. Bleeding can occur as the result of a number of different conditions, some of which

More information

Non-alcoholic Fatty liver disease in children. Dr.S.Venkatesh Karthik Consultant Paediatric Hepatologist KTP-NUCMI, NUH, Singapore

Non-alcoholic Fatty liver disease in children. Dr.S.Venkatesh Karthik Consultant Paediatric Hepatologist KTP-NUCMI, NUH, Singapore Non-alcoholic Fatty liver disease in children Dr.S.Venkatesh Karthik Consultant Paediatric Hepatologist KTP-NUCMI, NUH, Singapore Relevance Leading cause of chronic liver disease- both adults and children

More information

Work up of the Asymptomatic Patient with Liver Enzyme Abnormalities

Work up of the Asymptomatic Patient with Liver Enzyme Abnormalities Work up of the Asymptomatic Patient with Liver Enzyme Abnormalities G.Y. Minuk Professor of Medicine and Pharmacology University of Manitoba Head, Section of Hepatology Health Sciences Centre 2014 NDAFP

More information

Liver Cancer (1 of 5)

Liver Cancer (1 of 5) i If you need your information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 or send an email to: customercare@ salisbury.nhs.uk You are entitled

More information

Identify presence of elevated liver enzymes in otherwise healthy patients in outpatient medicine

Identify presence of elevated liver enzymes in otherwise healthy patients in outpatient medicine Patrick Louis Brine September 27 th Associate Program Director SEHC IM Residency Assistant Professor Northeast Ohio Medical University Clinical Adjunct Professor Lake Erie College of Osteopathic Medicine

More information

Jean. Gastrointestinal Cancers Program. p: (203) yalecancercenter.org. smilowcancer.org Yale Cancer Center

Jean. Gastrointestinal Cancers Program. p: (203) yalecancercenter.org. smilowcancer.org Yale Cancer Center INTRODUCTION APPOINTMENTS P ancreatic cancer is a difficult diagnosis that affects over 45,000 people in the United States each year. Thankfully, improved understanding of risk factors for the disease,

More information

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine

Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...

More information

Digestive Disorders Center

Digestive Disorders Center Digestive Disorders Center 200 Lothrop St. Pittsburgh, PA 15213-2582 412-647-8666 toll-free, 1-866-4GASTRO (442-7876) http://gi.medicine.pitt.edu To find a UPMC doctor, call 412-647-UPMC (8762) or 800-533-UPMC.

More information

EMR Decision Tool. Clinical and functional elements for EMR software

EMR Decision Tool. Clinical and functional elements for EMR software EMR Decision Tool Clinical and functional elements for EMR software AGA Institute EMR Clinical and Functional Elements EMR Decision Tool To assist gastroenterologists in the decision process needed to

More information

Normal values Total serum protein Total protein: Albumin: Globulin: Albumin/globulin ratio:

Normal values Total serum protein Total protein: Albumin: Globulin: Albumin/globulin ratio: Serum proteins Normal values Total serum protein Total protein: 5.5 9.0 grams per deciliter (g/dl) Albumin:3.5 5.5 g/dl Globulin:2.0 3.5 g/dl Albumin/globulin ratio: Greater than 1.0 ALBUMIN Is the most

More information

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities

Role of Body Weight Reduction in Obesity-Associated Co-Morbidities Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:

More information

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed January 2013 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes it?

More information

Adult Health Nursing

Adult Health Nursing Adult Health Nursing 1. Course Title: Adult Nursing 2. Course Number: (301) 3. Credit Hours: Total (6) credits: Theory (3) credits Clinical (3) credits 4. Course Calendar: Total (12) hours Weekly of (15)

More information

NICE guideline Published: 6 July 2016 nice.org.uk/guidance/ng49

NICE guideline Published: 6 July 2016 nice.org.uk/guidance/ng49 Non-alcoholic fatty liver disease (NAFLD): assessment and management NICE guideline Published: 6 July 2016 nice.org.uk/guidance/ng49 NICE 2016. All rights reserved. Your responsibility The recommendations

More information

Differential Diagnosis of NAFLD- A Short Summary:

Differential Diagnosis of NAFLD- A Short Summary: Differential Diagnosis of NAFLD- A Short Summary: Almost a fifth of our general pediatric population is now classified as overweight in the United States. When such children present with elevated liver

More information

Extrahepatic bile duct cancer is a rare disease in which malignant (cancer) cells form in the part of bile duct that is outside the liver.

Extrahepatic bile duct cancer is a rare disease in which malignant (cancer) cells form in the part of bile duct that is outside the liver. EXTRAHEPATIC BILE DUCT CANCER General Information Extrahepatic bile duct cancer is a rare disease in which malignant (cancer) cells form in the part of bile duct that is outside the liver. A network of

More information

LIVER CARE CENTER. stlouischildrens.org

LIVER CARE CENTER. stlouischildrens.org LIVER CARE CENTER stlouischildrens.org One of North America s Premier Pediatric Liver Care Centers The Liver Care Center at St. Louis Children s Hospital and Washington University School of Medicine is

More information

Evaluation and Prognosis of Patients with Cirrhosis

Evaluation and Prognosis of Patients with Cirrhosis Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded

More information

The child with abnormal liver function tests

The child with abnormal liver function tests The child with abnormal liver function tests Dr Jane Hartley Consultant Paediatric Hepatologist Birmingham Children s Hospital, UK 1 st Global Congress CIP, Paris 2011 Contents Over view of liver anatomy,

More information

Non-alcoholic fatty liver disease: Prognosis and Treatment

Non-alcoholic fatty liver disease: Prognosis and Treatment Non-alcoholic fatty liver disease: Prognosis and Treatment Zachary Henry, M.D. Assistant Professor UVA Gastroenterology & Hepatology October 28, 2015 Overview Case Presentation Prognosis Effects of fibrosis

More information

BLU-554, A Novel, Potent and Selective Inhibitor of FGFR4 for the Treatment of Liver Cancer

BLU-554, A Novel, Potent and Selective Inhibitor of FGFR4 for the Treatment of Liver Cancer BLU-554, A Novel, Potent and Selective Inhibitor of FGFR4 for the Treatment of Liver Cancer Dr Klaus Hoeflich, PhD Director of Biology, Blueprint Medicines Disclosures Employee and shareholder of Blueprint

More information

SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN

SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN SUMMER SCHOOL organised by the Hepatology Committee of ESPGHAN Paediatric Hepatology: from basic science to daily practice June 13-16th, 2012 Bordeaux, France Program European Society for Paediatric Gastroenterology,

More information

Evaluation of Liver Function tests in Primary Care. Abid Suddle Institute of Liver Studies, KCH

Evaluation of Liver Function tests in Primary Care. Abid Suddle Institute of Liver Studies, KCH Evaluation of Liver Function tests in Primary Care Abid Suddle Institute of Liver Studies, KCH Liver Function tests Markers of hepatocellular damage Cholestasis Liver synthetic function Markers of Hepatocellular

More information

PSC and Your Liver: How to Keep Your Liver Healthy: Myths and Reality

PSC and Your Liver: How to Keep Your Liver Healthy: Myths and Reality PSC and Your Liver: How to Keep Your Liver Healthy: Myths and Reality Kapil Chopra, MD Associate Professor of Medicine Clinical Director of Hepatology PSC Liver: Pubmed Publications 100 90 80 70 60 50

More information

Genetic Testing in Research & Healthcare

Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes

More information

BILE ACID SYNTHESIS AND METABOLISM DEFECTS

BILE ACID SYNTHESIS AND METABOLISM DEFECTS The Childhood Liver Disease Research Network strives to provide information and support to individuals and families affected by liver disease through its many research programs. BILE ACID SYNTHESIS AND

More information

New York State Living Liver Donor Data Deliverables

New York State Living Liver Donor Data Deliverables New York State Living Liver Donor Data Deliverables A Report to: New York State Department of Health March 2015 Living Liver Donor Data Deliverables Living liver donation has received increasing attention

More information

Liver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology

Liver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology Liver, Gallbladder and Pancreas diseases Premed 2 Pathophysiology Pancreas Pancreatitis Acute Pancreatitis Autodigestion of the pancreas due to activation of the enzymes Hemorrhagic fat necrosis, calcium

More information

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS Your health is important to us! The test descriptions listed below are for educational purposes only. Laboratory test interpretation

More information

Learning objectives :

Learning objectives : Learning objectives : Definition of Jaundice The normal plasma concentration of total bilirubin Classification of jaundice: Prehepatic(hemolytic)jaundice Hepatic(hepatocellular)jaundice Poshepatic(obstructive)jaundic

More information

Principles of Gastroenterology. Nurse Practitioner and Physician Assistant. for the. Aug. 10 12, 2012 InterContinental Chicago

Principles of Gastroenterology. Nurse Practitioner and Physician Assistant. for the. Aug. 10 12, 2012 InterContinental Chicago Principles of Gastroenterology for the Nurse Practitioner and Physician Assistant Aug. 10 12, 2012 InterContinental Chicago Course Directors Lawrence R. Kosinski, MD, MBA, AGAF, FAGC Sandra Bernklau, MSN,

More information

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s! How to Interpret and Use Them René Romero, M.D. Clinical Director, Pediatric Hepatology CPG Gastroenterology, Hepatology and Nutrition Emory University School of Medicine Objectives Understand the anatomy

More information

ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits

ELEMENTS FOR A PUBLIC SUMMARY. Overview of disease epidemiology. Summary of treatment benefits VI: 2 ELEMENTS FOR A PUBLIC SUMMARY Bicalutamide (CASODEX 1 ) is a hormonal therapy anticancer agent, used for the treatment of prostate cancer. Hormones are chemical messengers that help to control the

More information

2014 Fatty Liver Disease

2014 Fatty Liver Disease 2014 Fatty Liver Disease Fatty Liver Disease Fatty liver disease happens when there is a buildup of extra fat cells in the liver. A liver is fatty when fat makes up 5-10% of the liver. Simple fatty liver

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

BURDEN OF LIVER DISEASE IN BRAZIL

BURDEN OF LIVER DISEASE IN BRAZIL BURDEN OF LIVER DISEASE IN BRAZIL Burden of Liver Disease in Europe Blachier et al. J Hepatol 58:593, 2013 Review of 260 epidemiologic studies of the 5 previous years Cirrhosis is responsible for 170.000

More information

R e c o m m e n d e d Sc r e e n i n g s, T e s t s, a n d Im m u n i z a t i o n s f o r

R e c o m m e n d e d Sc r e e n i n g s, T e s t s, a n d Im m u n i z a t i o n s f o r Does your family history include? High blood pressure High cholesterol Heart disease, heart disease before age 50 in a male relative or before age 60 in a female relative, or heart attack Diabetes Breast

More information

A913: Liver cancer. General facts of Liver cancer

A913: Liver cancer. General facts of Liver cancer General facts of Liver cancer A913: Liver cancer There are two different types of primary liver cancer. The most common kind is called hepatoma or hepatocellular carcinoma (HCC), and arises from the main

More information

Gastrointestinal & Hepatic- Biliary Systems

Gastrointestinal & Hepatic- Biliary Systems Objectives Gastrointestinal & Hepatic- Biliary Systems Chapter 5 Part II Review the general signs & symptoms associated with lower GI pathology Discuss the common illnesses/conditions involving the lower

More information

This program is jointly provided by the New York Society for Gastrointestinal Endoscopy and Mount Sinai Beth Israel

This program is jointly provided by the New York Society for Gastrointestinal Endoscopy and Mount Sinai Beth Israel This program is jointly provided by the New York Society for Gastrointestinal Endoscopy and Mount Sinai Beth Israel Japan Society 333 East 47th Street (near First Avenue) 10017 COURSE DESCRIPTION The Spring

More information

Jaundice. Michael Ornes

Jaundice. Michael Ornes Jaundice Michael Ornes Definitions Jaundice: hyperbilirubinemia leading to yellow discoloration of the skin Icterus: hyperbilirubinemia leading to yellow discoloration of the sclera Usually undetectable

More information

脂肪肝的西醫藥治療 Western medicine treatment on fatty liver. Vincent Wong 黃煒燊 Institute of Digestive Disease 消化疾病研究所

脂肪肝的西醫藥治療 Western medicine treatment on fatty liver. Vincent Wong 黃煒燊 Institute of Digestive Disease 消化疾病研究所 脂肪肝的西醫藥治療 Western medicine treatment on fatty liver Vincent Wong 黃煒燊 Institute of Digestive Disease 消化疾病研究所 Disclosures Advisory board member: AbbVie, Gilead, Janssen, Otsuka, Roche Consultancy: Merck,

More information

NOVEL PLATFORMS FOR CANCER DIAGNOSIS

NOVEL PLATFORMS FOR CANCER DIAGNOSIS NOVEL PLATFORMS FOR CANCER DIAGNOSIS Luca Beneduce, Ph.D. Founded in 2001 and headquartered in Venice (Italy) Xeptagen is a privately held biotech company funded by venture capital. Xeptagen s mission

More information

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed January 2016 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes it?

More information

Comparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases

Comparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases Available online at wwwpelagiaresearchlibrarycom European Journal of Experimental Biology, 2013, 3(2):280-284 ISSN: 2248 9215 CODEN (USA): EJEBAU Comparative Levels of ALT, AST, ALP and GGT in Liver associated

More information

LIVER FUNCTION ABNORMALITIES FALL INTO 2 MAIN GROUPS: 1) HEPATIC INJURY 2) CHOLESTATIC

LIVER FUNCTION ABNORMALITIES FALL INTO 2 MAIN GROUPS: 1) HEPATIC INJURY 2) CHOLESTATIC HEPATIC DISEASE LIVER FUNCTION ABNORMALITIES FALL INTO 2 MAIN GROUPS: 1) HEPATIC INJURY 2) CHOLESTATIC LFT s HEPATIC INJURY: ALT (5-40) AST (5-40) CHOLESTASIS: ALP (30-120) & GGT (5-65) (together) NONSPECIFIC

More information

Research in IBD at University of Colorado Denver

Research in IBD at University of Colorado Denver Research in IBD at University of Colorado Denver Blair Fennimore, MD Assistant Professor of Medicine Division of Gastroenterology and Hepatology UCH Crohn s and Colitis Center Mucosal Inflammation Program

More information

DIET IN DISORDERS OF LIVER

DIET IN DISORDERS OF LIVER DIET IN DISORDERS OF LIVER See inside.. Introduction Liver diseases Dietary care & management Conclusion Introduction Liver is the largest gland in the body, which plays a vital role, performing many complex

More information

GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo

GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo Educational Purpose: The Hepatology Rotation introduces the fellow to the management of outpatients and inpatients

More information

Cancer of the duodenum (ICD10 C17.0)

Cancer of the duodenum (ICD10 C17.0) Cancer of the duodenum (ICD10 C17.0) In England cancers of the duodenum account for approximately 3% of all cancers arising in the hepatobiliary tract and are equally common in men and women (M to F ratio

More information

What's the Best Approach to Evaluate the Liver Mass?

What's the Best Approach to Evaluate the Liver Mass? WHAT IS THE BEST WAY TO EVALUATE THE LIVER MASS? Mitchell L Shiffman, MD Chief, Hepatology Section Virginia Commonwealth University Medical Center Richmond, VA LIVER MASSES DISCOVERY AND SIGNIFICANCE Incidental

More information

Endpoints and Populations and Trial Designs for Clinical Trials in NASH Indications

Endpoints and Populations and Trial Designs for Clinical Trials in NASH Indications Endpoints and Populations and Trial Designs for Clinical Trials in NASH Indications Lara Dimick-Santos, MD Food and Drug Administration The Liver Forum November 12, 2015 1 Disclaimer The views presented

More information

Other commonly known names of vitamin A include Retinol, Retinal, Retinoic acid and Carotenoids.

Other commonly known names of vitamin A include Retinol, Retinal, Retinoic acid and Carotenoids. Medical Nutrition Therapy Nutrient: Vitamin A 1. What is the nutrient? Vitamin A is a fat-soluble group of retinoids including retinol, retinal, retinoic acid and retinyl esters. Vitamin A is involved

More information

Colon and Rectal Cancer

Colon and Rectal Cancer Colon and Rectal Cancer What is colon or rectal cancer? Colon or rectal cancer is the growth of abnormal cells in your large intestine, which is also called the large bowel. The colon is the last 5 feet

More information